Publications by authors named "Sandra Lippold"

Claim this Profile
C
Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110.
Silke Petsch, Olivier Gires, Dominik Rüttinger, Sabine Denzel, Sandra Lippold

MAbs· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3.
Maria Amann, Klaus Brischwein, Petra Lutterbuese, Larissa Parr, Laetitia Petersen, Sandra Lippold

Cancer Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exchanging human Fcgamma1 with murine Fcgamma2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model.
Petra Lutterbuese, Klaus Brischwein, Robert Hofmeister, Sandrine Crommer, Grit Lorenczewski, Sandra Lippold

Cancer Immunol Immunother· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3.
Bernd Schlereth, Petra Kleindienst, Iduna Fichtner, Grit Lorenczewski, Klaus Brischwein, Sandra Lippold

Cancer Immunol Immunother· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct.
Bernd Schlereth, Cornelia Quadt, Torsten Dreier, Peter Kufer, Grit Lorenczewski, Sandra Lippold

Cancer Immunol Immunother· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G.
Susanne Preithner, Stefanie Elm, Sandra Lippold, Mathias Locher, Andreas Wolf

Mol Immunol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment.
Stefanie Naundorf, Susanne Preithner, Petra Mayer, Sandra Lippold, Andreas Wolf

Int J Cancer· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis